23 Jun, 2020 RNAi Roundtable: ALN-AGT, in Development for the Treatment of Hypertension
Posted at 14:41h
in Capella
On June 23, 2020, we hosted an online RNAi Roundtable to review the progress with ALN-AGT, an RNAi therapeutic in development for the treatment of hypertension.
Access the replay
View the presentation
Read the transcript
John Maraganore, Ph.D.
Chief Executive Officer
Akshay Desai, M.D., M.P.H.
Director, Cardiomyopathy and Heart Failure Program, Cardiovascular Division, Brigham and Women’s Hospital;
Associate Professor of Medicine, Harvard Medical School
Jae Kim, M.D.
Vice President, Clinical Development
Lauren Melton
Senior Director, Program Leader, ALN-AGT
